Tiszavasvári, Hungary

Judit Barkanyi

This inventor holds 1 USPTO granted patent. Top assignee: Alkaloida Vegyeszeti Gyar. Active years: 1994.


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Judit Barkanyi

Introduction

Judit Barkanyi is a notable inventor based in Tiszavasvári, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release preparations. Her work has the potential to enhance the efficacy of various medications.

Latest Patents

Judit Barkanyi holds a patent for a "Controlled release pharmaceutical preparation and process for preparing." This innovative preparation involves homogenizing various pharmaceutical active substances, including opium alkaloids and their salts, to create a continuous phase transfer. The formulation also incorporates an ethylene vinyl acetate copolymer, which is essential for achieving the desired release characteristics.

Career Highlights

Barkanyi's career is marked by her dedication to pharmaceutical innovation. She has worked at Alkaloida Vegyeszeti Gyar, where she has been instrumental in advancing the company's research and development efforts. Her patent reflects her commitment to improving drug delivery systems and patient outcomes.

Collaborations

Throughout her career, Judit has collaborated with esteemed colleagues, including Imre Gulyas and Jozsef Nagy. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Judit Barkanyi's contributions to the pharmaceutical industry exemplify the impact of innovative thinking in medicine. Her work on controlled release preparations showcases her expertise and commitment to enhancing drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…